আইসলণ্ড -
আইসল্যান্ডীয় -
LYFJASTOFNUN (Icelandic Medicines Agency)
seroxat filmuhúðuð tafla 20 mg
glaxosmithkline pharma a/s - paroxetinum hýdróklóríð - filmuhúðuð tafla - 20 mg
আইসলণ্ড -
আইসল্যান্ডীয় -
LYFJASTOFNUN (Icelandic Medicines Agency)
seroxat filmuhúðuð tafla 10 mg
glaxosmithkline pharma a/s - paroxetinum hýdróklóríð - filmuhúðuð tafla - 10 mg
আইসলণ্ড -
আইসল্যান্ডীয় -
LYFJASTOFNUN (Icelandic Medicines Agency)
engerix b stungulyf, dreifa
glaxosmithkline pharma a/s - lifrarbólgu b yfirborðsmótefnavaki - stungulyf, dreifa
আইসলণ্ড -
আইসল্যান্ডীয় -
LYFJASTOFNUN (Icelandic Medicines Agency)
boostrix stungulyf, dreifa áfyllt sprauta
glaxosmithkline pharma a/s - pertussis toxoid; filamentous haemagglutinin; pertactin; diphtheria toxoid; tetanus toxoid - stungulyf, dreifa - áfyllt sprauta
আইসলণ্ড -
আইসল্যান্ডীয় -
LYFJASTOFNUN (Icelandic Medicines Agency)
boostrix polio stungulyf, dreifa áfyllt sprauta
glaxosmithkline pharma a/s - diphtheria toxoid; tetanus toxoid; pertussis toxoid; filamentous haemagglutinin; pertactin; poliovirus inactivated type 1; poliovirus inactivated type 2; poliovirus inactivated type 3 - stungulyf, dreifa - áfyllt sprauta
আইসলণ্ড -
আইসল্যান্ডীয় -
LYFJASTOFNUN (Icelandic Medicines Agency)
duac hlaup
stiefel laboratories legacy (ireland) ltd - benzoylis peroxidum; clindamycinum fosfat - hlaup
আইসলণ্ড -
আইসল্যান্ডীয় -
LYFJASTOFNUN (Icelandic Medicines Agency)
duodart hart hylki 0,5/0,4 mg
glaxosmithkline pharma a/s - dutasteridum inn; tamsulosinum hýdróklóríð - hart hylki - 0,5/0,4 mg
আইসলণ্ড -
আইসল্যান্ডীয় -
LYFJASTOFNUN (Icelandic Medicines Agency)
wellbutrin retard (lyfjaver) tafla með breyttan losunarhraða 150 mg
lyfjaver ehf. - bupropionum inn hýdróklóríð - tafla með breyttan losunarhraða - 150 mg
আইসলণ্ড -
আইসল্যান্ডীয় -
LYFJASTOFNUN (Icelandic Medicines Agency)
wellbutrin retard (lyfjaver) tafla með breyttan losunarhraða 300 mg
lyfjaver ehf. - bupropionum inn hýdróklóríð - tafla með breyttan losunarhraða - 300 mg
ইউরোপীয় ইউনিয়ন -
আইসল্যান্ডীয় -
EMA (European Medicines Agency)
bexsero
gsk vaccines s.r.l. - ytri himnu frá neisseria meningitidis hópur b (álag nýja-sjáland 98/254), skal læknir hafa neisseria meningitidis hópur b fhbp samruna prótín, skal læknir hafa neisseria meningitidis hópur b nada prótín, skal læknir hafa neisseria meningitidis hópur b nhba samruna prótín - meningitis, meningococcal - meningókokka bóluefni - virkt ónæmisaðgerðir gegn innrásarsjúkdómum af völdum neisseria meningitidis serogroup-b stofnanna.